Abstract |
Beta-lactam antibiotics include penicillins, cephalosporins and related compounds. As a group, these drugs are active against many gram-positive, gram-negative and anaerobic organisms. Information based on "expert opinion" and antimicrobial susceptibility testing supports certain antibiotic choices for the treatment of common infections, but less evidence-based literature is available to guide treatment decisions. Evidence in the literature supports the selection of amoxicillin as first-line antibiotic therapy for acute otitis media. Alternative drugs, such as amoxicillin- clavulanate, trimethoprim-sulfamethoxazole and cefuroxime axetil, can be used to treat resistant infections. Penicillin V remains the drug of choice for the treatment of pharyngitis caused by group A streptococci. Inexpensive narrow-spectrum drugs such as amoxicillin or trimethoprim-sulfamethoxazole are first-line therapy for sinusitis. Animal and human bites can be treated most effectively with amoxicillin- clavulanate. For most outpatient procedures, amoxicillin is the preferred agent for bacterial endocarditis prophylaxis. Beta-lactam antibiotics are usually not the first choice for empiric outpatient treatment of community-acquired pneumonia. Based on the literature, the role of beta-lactam antibiotics in the treatment of bronchitis, skin infections and urinary tract infections remains unclear.
|
Authors | K B Holten, E M Onusko |
Journal | American family physician
(Am Fam Physician)
Vol. 62
Issue 3
Pg. 611-20
(Aug 01 2000)
ISSN: 0002-838X [Print] United States |
PMID | 10950216
(Publication Type: Journal Article, Review)
|
Chemical References |
- Anti-Bacterial Agents
- beta-Lactams
|
Topics |
- Administration, Oral
- Adult
- Anti-Bacterial Agents
(administration & dosage, adverse effects, classification, therapeutic use)
- Bacterial Infections
(drug therapy)
- Drug Prescriptions
- Humans
- beta-Lactams
|